These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions. Gubbiotti MA; Vallet SD; Ricard-Blum S; Iozzo RV Matrix Biol; 2016 Sep; 55():7-21. PubMed ID: 27693454 [TBL] [Abstract][Full Text] [Related]
16. The Role of Decorin and Biglycan Signaling in Tumorigenesis. Diehl V; Huber LS; Trebicka J; Wygrecka M; Iozzo RV; Schaefer L Front Oncol; 2021; 11():801801. PubMed ID: 34917515 [TBL] [Abstract][Full Text] [Related]
17. Decorin-mediated oncosuppression - a potential future adjuvant therapy for human epithelial cancers. Sainio AO; Järveläinen HT Br J Pharmacol; 2019 Jan; 176(1):5-15. PubMed ID: 29488209 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Ständer M; Naumann U; Wick W; Weller M Cell Tissue Res; 1999 May; 296(2):221-7. PubMed ID: 10382266 [TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs. Goldoni S; Iozzo RV Int J Cancer; 2008 Dec; 123(11):2473-9. PubMed ID: 18798267 [TBL] [Abstract][Full Text] [Related]
20. Decreased decorin expression in the tumor microenvironment. Bozoky B; Savchenko A; Guven H; Ponten F; Klein G; Szekely L Cancer Med; 2014 Jun; 3(3):485-91. PubMed ID: 24634138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]